Jeremy C. Parker

Jeremy C. Parker

Auto-generated profile, based on publicly available information

Jeremy C. Parker

Centre for Infection and Immunity, Queen's University Belfast, Belfast, Northern Ireland

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
RVRémi Villenave
Rémi Villenave
STSurendran Thavagnanam
Surendran Thavagnanam
SSSeverine Sarlang
Severine Sarlang
JPJeremy Parker
Jeremy Parker
IDIsobel Douglas
Isobel Douglas
Ultan PowerUltan Power
Ultan Power
Respiratory syncytial virus (RSV) is the major viral cause of severe pulmonary disease in young infants worldwide. However, the mechanisms by which RSV causes disease in humans remain poorly understood. To help bridge this gap, we developed an ex vivo/in vitro model of RSV infection based on well-differentiated primary pediatric bronchial epithelial cells (WD-PBECs), the primary targets of RSV infection in vivo. Our RSV/WD-PBEC model demonstrated remarkable similarities to hallmarks of RSV infection in infant lungs. These hallmarks included restriction of infection to noncontiguous or small clumps of apical ciliated and occasional nonciliated epithelial cells, apoptosis and sloughing of apical epithelial cells, occasional syncytium formation, goblet cell hyperplasia/metaplasia, and mucus hypersecretion. RSV was shed exclusively from the apical surface at titers consistent with those in airway aspirates from hospitalized infants. Furthermore, secretion of proinflammatory chemokines such as CXCL10, CCL5, IL-6, and CXCL8 reflected those chemokines present in airway aspirates. Interestingly, a recent RSV clinical isolate induced more cytopathogenesis than the prototypic A2 strain. Our findings indicate that this RSV/WD-PBEC model provides an authentic surrogate for RSV infection of airway epithelium in vivo. As such, this model may provide insights into RSV pathogenesis in humans that ultimately lead to successful RSV vaccines or therapeutics.

1 January 2010 in Pediatric Research
Verified
Journal Article
Closed access
JPJeremy Parker
Jeremy Parker
SSSeverine Sarlang
Severine Sarlang
STSurendran Thavagnanam
Surendran Thavagnanam
GWGrace Williamson
Grace Williamson
DODara O'DOnoghue
Dara O'DOnoghue
GSGrzegorz Skibinski
Grzegorz Skibinski

16 July 2002 in Diabetologia
Verified
Journal Article
Closed access
PDF file
FOFinbarr O'Harte
Finbarr O'Harte
Victor GaultVictor Gault
Victor Gault
JPJ. Parker
J. Parker
PHP. Harriott
P. Harriott
MMM. Mooney
M. Mooney
Peter R FlattPeter R Flatt
Peter R Flatt

9 May 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JPJeremy C. Parker
Jeremy C. Parker
STSurendran Thavagnanam
Surendran Thavagnanam
GSGrzegorz Skibinski
Grzegorz Skibinski
JLJeremy Lyons
Jeremy Lyons
JBJennifer Bell
Jennifer Bell
MSMichael D. Shields
Michael D. Shields
Asthma is a chronic inflammatory disease characterised by airways remodelling. In mouse models IL-9 and IL-13 have been implicated in airways remodelling including mucus hypersecretion and goblet cell hyperplasia. Their role, especially that of IL-9, has been much less studied in authentic human ex vivo models of the bronchial epithelium from normal and asthmatic children. We assessed the effects of IL-9, IL-13 and an IL-9/IL-13 combination, during differentiation of bronchial epithelial cells from normal (n = 6) and asthmatic (n = 8) children. Cultures were analysed for morphological markers and factors associated with altered differentiation (MUC5AC, SPDEF and MMP-7). IL-9, IL-9/IL-13 combination and IL-13 stimulated bronchial epithelial cells from normal children had fewer ciliated cells [14.8% (SD 8.9), p = 0.048, 12.4 (SD 6.1), p = 0.016 and 7.3% (SD 6.6), p = 0.031] respectively compared with unstimulated [(21.4% (SD 9.6)]. IL-9 stimulation had no effect on goblet cell number in either group whereas IL-9/IL-13 combination and IL-13 significantly increased goblet cell number [24.8% (SD 8.8), p = 0.02), 32.9% (SD 8.6), p = 0.007] compared with unstimulated normal bronchial cells [(18.6% (SD 6.2)]. All stimulations increased MUC5AC mRNA in bronchial epithelial cells from normal children and increased MUC5AC mucin secretion. MMP-7 localisation was dysregulated in normal bronchial epithelium stimulated with Th2 cytokines which resembled the unstimulated bronchial epithelium of asthmatic children. All stimulations resulted in a significant reduction in transepithelial electrical resistance values over time suggesting a role in altered tight junction formation. We conclude that IL-9 does not increase goblet cell numbers in bronchial epithelial cell cultures from normal or asthmatic children. IL-9 and IL-13 alone and in combination, reduce ciliated cell numbers and transepithelial electrical resistance during differentiation of normal epithelium, which clinically could inhibit mucociliary clearance and drive an altered repair mechanism. This suggests an alternative role for IL-9 in airways remodelling and reaffirms IL-9 as a potential therapeutic target.

1 February 2011 in Pediatric Research
Verified
Journal Article
Closed access
PDF file
STSurendran Thavagnanam
Surendran Thavagnanam
JPJeremy C Parker
Jeremy C Parker
MMMichael E McBrien
Michael E McBrien
GSGrzegorz Skibinski
Grzegorz Skibinski
LHLiam G Heaney
Liam G Heaney
MSMichael D Shields
Michael D Shields

15 November 2010 in Journal of Virology
Verified
Journal Article
Closed access
RVRémI Villenave
RémI Villenave
OTOlivier Touzelet
Olivier Touzelet
STSurendran Thavagnanam
Surendran Thavagnanam
SSSeverine Sarlang
Severine Sarlang
JPJeremy Parker
Jeremy Parker
Ultan PowerUltan Power
Ultan Power
Sendai virus (SeV) is a murine respiratory virus of considerable interest as a gene therapy or vaccine vector, as it is considered nonpathogenic in humans. However, little is known about its interaction with the human respiratory tract. To address this, we developed a model of respiratory virus infection based on well-differentiated primary pediatric bronchial epithelial cells (WD-PBECs). These physiologically authentic cultures are comprised of polarized pseudostratified multilayered epithelium containing ciliated, goblet, and basal cells and intact tight junctions. To facilitate our studies, we rescued a replication-competent recombinant SeV expressing enhanced green fluorescent protein (rSeV/eGFP). rSeV/eGFP infected WD-PBECs efficiently and progressively and was restricted to ciliated and nonciliated cells, not goblet cells, on the apical surface. Considerable cytopathology was evident in the rSeV/eGFP-infected cultures postinfection. This manifested itself by ciliostasis, cell sloughing, apoptosis, and extensive degeneration of WD-PBEC cultures. Syncytia were also evident, along with significant basolateral secretion of proinflammatory chemokines, including IP-10, RANTES, tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), interleukin 6 (IL-6), and IL-8. Such deleterious responses are difficult to reconcile with a lack of pathogenesis in humans and suggest that caution may be required in exploiting replication-competent SeV as a vaccine vector. Alternatively, such robust responses might constitute appropriate normal host responses to viral infection and be a prerequisite for the induction of efficient immune responses.